Ultrasound test for men on active surveillance for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study checks whether a new, small ultrasound approach can help confirm prostate cancer during active surveillance. It may help by providing a safer or more targeted way to decide whether ongoing monitoring is still enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult man (adult age).
- You have prostate cancer that is Gleason Grade Group 1.
- You are currently being followed with active surveillance (watching closely instead of immediate treatment).
- Your care plan includes needing a confirmatory prostate biopsy soon (a follow-up biopsy to confirm the cancer status).
- You must be able to have a prostate MRI scan.
- You must be able to have a prostate biopsy (the doctor can safely collect a tissue sample).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a special prostate scan called PSMA PET-CT (along with standard monitoring scans) can help guide care while you are on “active surveillance” instead of immediate treatment. It may help doctors track low-risk prostate cancer changes more accurately over time.
This trial tests if a new type of ultrasound (micro-ultrasound) can better detect important prostate cancers in men who are on active surveillance or newly eligible. It may help you avoid unnecessary biopsies while catching cancers that need treatment.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This study checks whether people with a low chance of prostate cancer can be monitored closely without having an immediate prostate biopsy. It uses PSA blood tests and prostate MRI to sort who may safely wait.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.